Established in 2014, Seaport Diagnostics's mission is to help lead the way in changing the diagnostic testing landscape by increasing its accessibility. On the foundation of automation, software, and logistics technologies utilized in our CLIA-certified laboratories, we have been able to seamlessly embark on our next phase as a company into the clinical diagnostics field. We now offer COVID-19 testing, respiratory pathogen testing, molecular UTI testing, and HbA1c testing in addition to our consumer genetic testing and personalized vitamins. Contact us today to learn more.
Location: United States, Massachusetts, Boston
Employees: 11-50
Investors 1
| Date | Name | Website |
| 23.11.2021 | Syno Capit... | synocapita... |
Mentions in press and media 1
| Date | Title | Description |
| 10.01.2023 | Nest Genomics Raises $8.5M to Increase Access to Patients’ Genetic Information | More and more healthcare providers are recognizing the critical role that genomics software plays in the advancement of precision medicine. Investors are getting behind genomics as well, as evidenced by the $8.5 million seed financing round... |